The PRMA Healthcheck®: the future of market access in Asia-Pacific
The PRMA Healthcheck® digital application provides a systematic, robust, and consistent approach to analyzing the many factors that influence pricing, reimbursement, and market access in the Asia-Pacific region.
Fill in your details to watch this webinar
This on-demand webinar describes how the PRMA Healthcheck®:
- benefits manufacturers by providing an assessment framework specifically focused on the Asia-Pacific region
- uses a four-step process to critically review the value of assets in the region and identify actions required to mitigate risk
- links global thinking with affiliate needs
- offers timely and consistent feedback to inform the target product profile.
Jan has more than 25 years’ experience in the pharmaceutical industry, including 4 years as a clinical trial statistician and 11 years in health outcomes at Eli Lilly in the UK. At PRMA Consulting, Jan leads and provides strategic input into projects to develop the evidence base to support the value of products, including translating that information into HTA submissions. She is responsible for setting the vision for the PRMA Healthcheck® digital application, which has been used to determine evidence generation strategies to support optimal market access outcomes in Europe, the US, and the Asia-Pacific region.
Duration: 15 minutes
Ideal viewing: Global Market Access, Global HEOR – particularly those who are involved in the Asia-Pacific region.
“The provided by the PRMA Healthcheck® takes us beyond market access and into commercialization. It has enabled us to evaluate commercial risk and opportunity throughout the development pathway.”
Executive Director, Integrated Market Access Team, top-10 pharmaceutical company